Trials available for people aged 51 to 65 years

PEACHI-03 Hepatitis C Vaccine Trial A Phase I Dose-Escalation Study to Evaluate the Safety and Immunogenicity of Prime-Boost Immunisations with Candidate HCV Vaccines, AdCh3 li-NSmut1 and MVA li-NSmut, in Healthy Volunteers.  For more detailed information about this trial, please click here.